• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

MJH COVID-19 Coalition to hold free webinar on treatment landscape


The free webinar will be held at 6 p.m. EDT on Oct. 13.

As the COVID-19 coronavirus pandemic continues to work its way through the country, the treatment landscape continues to shift seemingly by the day.

To clear the confusion on what helps and what hurts patients the MJH Life Sciences COVID-19 Coalition will host a free webinar at 6 p.m. EDT on Oct. 13 entitled “Navigating the COVID-19 Treatment Landscape,” which will feature a trio of experts discussing the latest in antivirals, anti-inflammatory therapies, corticosteroids, and convalescent plasma.

Click here to register for the free webinar.

The experts will help you stay up to speed on all the current agents in the physician’s arsenal to combat COVID-19.

Participants in this webinar will be:

  • Moderator Jason M. Pogue, PharmD, BCPS, BCIDP, a clinical professor at the University of Michigan College of Pharmacy and an infectious diseases clinical pharmacist at Michigan Medicine. His research interests focus on epidemiology and management of multi-drug resistant Gram-negative organisms and antimicrobial stewardship.
  • Panelist Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, a clinical professor at Temple University School of Pharmacy and clinical pharmacy specialist at Temple University Hospital where he maintains a clinical practice. He is currently the president of the Society of Infectious Diseases Pharmacists and the editor-in-chief of Contagion.
  • Panelist Susan Davis, PharmD, a clinical professor of pharmacy practice at Wayne State University with a joint appointment as infectious diseases pharmacy specialist at Henry Ford Health System. She has published more than 80 peer-reviewed manuscripts in the field of antimicrobial pharmacotherapy.
Related Videos